| scholarly article | Q13442814 |
| P50 | author | Ragnhild A. Lothe | Q11996941 |
| P2093 | author name string | Chen Y | |
| Clausen OP | |||
| De Angelis P | |||
| Lehne G | |||
| Stokke T | |||
| Smedshammer L | |||
| P2860 | cites work | Isolation and expression of a complementary DNA that confers multidrug resistance | Q24295219 |
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression | Q27853401 | ||
| Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein | Q28188274 | ||
| Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction | Q33796247 | ||
| Expression of a multidrug-resistance gene in human tumors and tissues | Q34586576 | ||
| Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine | Q34620070 | ||
| MDR1 gene expression in primary colorectal carcinomas | Q35977393 | ||
| Understanding anticancer drug resistance: opportunities for modulation and impact on new drug design | Q36022425 | ||
| Clinical implications of multidrug resistance to chemotherapy | Q36546687 | ||
| Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations | Q37597399 | ||
| Glutathione S-transferases: role in alkylating agent resistance and possible target for modulation chemotherapy--a review. | Q37955790 | ||
| DNA flow cytometry in solid tumors: practical aspects and clinical applications. | Q38604398 | ||
| Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. | Q40451069 | ||
| Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer | Q40836534 | ||
| Flow cytometric analysis of multidrug-resistance-associated antigen (P-glycoprotein) and DNA ploidy in human colon cancer | Q41090493 | ||
| Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. | Q41643433 | ||
| Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells. | Q41734532 | ||
| Constitutive expression of multidrug resistance in human colorectal tumours and cell lines | Q42389991 | ||
| Phosphorylation of the Mr 170,000 to 180,000 glycoprotein specific to multidrug-resistant tumor cells: effects of verapamil, trifluoperazine, and phorbol esters. | Q42522544 | ||
| Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues | Q48913115 | ||
| The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. | Q52641814 | ||
| Drug-metabolizing enzyme expression in human normal, peritumoral and tumoral colorectal tissue samples. | Q53498685 | ||
| Detection of P-glycoprotein in solid tumors by flow cytometry. | Q54228205 | ||
| Expression of drug-metabolizing enzymes and P-170 glycoprotein in colorectal carcinoma and normal mucosa | Q54265683 | ||
| Assessment of P-glycoprotein, glutathione-based detoxifying enzymes and O6-alkylguanine-DNA alkyltransferase as potential indicators of constitutive drug resistance in human colorectal tumors | Q54698089 | ||
| Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer | Q58423655 | ||
| Enhanced expression of glutathione S-transferases in colorectal carcinoma compared to non-neoplastic mucosa | Q64445217 | ||
| Expression of a multidrug resistance gene in human cancers | Q69366790 | ||
| Glutathione S-transferases in normal and malignant human colon tissue | Q70141022 | ||
| Screening for TP53 mutations in osteosarcomas using constant denaturant gel electrophoresis (CDGE) | Q70484971 | ||
| Relationship between p53 gene mutations and multidrug resistance (mdr1) gene expression in myelodysplastic syndromes | Q72656838 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 307-311 | |
| P577 | publication date | 1995-08-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | P-glycoprotein is not expressed in a majority of colorectal carcinomas and is not regulated by mutant p53 in vivo | |
| P478 | volume | 72 |
| Q38986437 | A cisplatin-resistant head and neck cancer cell line with cytoplasmic p53(mut) exhibits ATP-binding cassette transporter upregulation and high glutathione levels. |
| Q37208654 | A new mdr-1 encoded P-170 specific monoclonal antibody: (6/1C) on paraffin wax embedded tissue without pretreatment of sections. |
| Q37641452 | Apoptosis and expression of Bax, Bcl-x, and Bcl-2 apoptotic regulatory proteins in colorectal carcinomas, and association with p53 genotype/phenotype |
| Q34580489 | Cancer chemoresistance: the relationship between p53 and multidrug transporters |
| Q64927462 | Changes in P-glycoprotein expression in gastric carcinoma with respect to distant gastric mucosa may be influenced by p53. |
| Q36617839 | Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes |
| Q35556544 | Decreased functional activity of multidrug resistance protein in primary colorectal cancer |
| Q34742986 | Expression of P-glycoprotein and p53 in advanced hepatocellular carcinoma treated by single agent chemotherapy: clinical correlation |
| Q37218281 | Expression of P-glycoprotein in hepatocellular carcinoma: a potential marker of prognosis |
| Q54125615 | Expression of P-glycoprotein, a multidrug-resistance gene product, is induced by radiotherapy in patients with oral squamous cell carcinoma. |
| Q36115974 | Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas |
| Q71740233 | MDR1 expression correlates with mutant p53 expression in colorectal cancer metastases |
| Q44672133 | Modulation of doxorubicin sensitivity by a novel organic compound, oxalyl bis (N-phenyl) hydroxamic acid on acetyl aminofluorene-induced preneoplastic hepatocytes |
| Q40788757 | Mutant p53 cooperates with ETS and selectively up-regulates human MDR1 not MRP1. |
| Q35550932 | Overcoming Antiapoptotic Responses to Promote Chemosensitivity in Metastatic Colorectal Cancer to the Liver |
| Q41129549 | P53 protein expression in human multidrug-resistant CEM lymphoblasts |
| Q73184474 | Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancer |
| Q74531411 | Proliferation-dependent expression and phosphorylation of pRB in B cell non-Hodgkin's lymphomas: dependence on RB1 copy number |
| Q35159123 | Regulation of expression of the multidrug resistance protein MRP1 by p53 in human prostate cancer cells |
| Q47370432 | Synthetically lethal nanoparticles for treatment of endometrial cancer. |
| Q33516216 | Visualization and enrichment of live putative cancer stem cell populations following p53 inactivation or Bax deletion using non-toxic fluorescent dyes. |
Search more.